External broker reports(aggregated public sources), Axis Direct

Axis Direct

External broker reports(aggregated public sources)

Axis Direct is the flagship brand under Axis Securities Limited, a subsidiary of Axis Bank in India. 

Content available is external broker reports authored by a third party outside the Smartkarma network and has been aggregated by an online aggregator through publicly available sources and is displayed by Smartkarma in this format for user's convenience and general informational purposes only. Content does not constitute investment or financial advice and Smartkarma makes no representation or warranty regarding its accuracy or contents. Original third party author retains all copyright and other proprietary rights in the content. Access or use of third party links not controlled by Smartkarma are at the user's own risk.

Equity Bottom-Up

<ul><li>Pharma Division – Sustained Momentum: The pharma packaging segment continued to deliver robust growth, with revenue increasing 45% QoQ to Rs 10.8 Cr, albeit on a low base (Rs 7.4 Cr in Q1FY26).</li><li>Management highlighted pharma packaging as a key structural growth driver, supported by new client additions, innovative product offerings, and increasing capacity utilization (&gt;50%).</li><li>The company reiterated its FY26 revenue target of Rs 35 Cr, with a peak potential of Rs 55–60 Cr at current capacity, indicating a meaningful contribution to margin expansion over the medium term.</li></ul>Content is external broker report sourced from online content aggregator through publicly available sources and is displayed below for general informational purposes only. Refer full disclaimer below.

Pharma Division – Sustained Momentum: The pharma packaging segment continued to deliver robust growth, with revenue increasing 45% QoQ to Rs 10.8 Cr, albeit on a low base (Rs 7.4 Cr in Q1FY26).Management highlighted pharma packaging as a key structural growth driver, supported by new client additions, innovative product offerings, and increasing capacity utilization (&gt;50%).The company reiterated its FY26 revenue target of Rs 35 Cr, with a peak potential of Rs 55–60 Cr at current capacity, indicating a meaningful contribution to margin expansion over the medium term.Content is external broker report sourced from online content aggregator through publicly available sources and is displayed below for general informational purposes only. Refer full disclaimer below.

Mold-Tek Packaging - Performance In Line with Expectations; Maintain BUY

<ul><li>Robust Performance Across Key Segments: The company reported strong volume growth of 15% YoY and 16.9% QoQ, indicating sustained operational momentum across all major business verticals.</li><li>This performance was underpinned by an optimised product mix and improved capacity utilisation.</li><li>Notably, the Paint Packs segment was a major growth contributor, registering a robust 28.3% QoQ increase in volumes.</li></ul>Content is external broker report sourced from online content aggregator through publicly available sources and is displayed below for general informational purposes only. Refer full disclaimer below.

Robust Performance Across Key Segments: The company reported strong volume growth of 15% YoY and 16.9% QoQ, indicating sustained operational momentum across all major business verticals.This performance was underpinned by an optimised product mix and improved capacity utilisation.Notably, the Paint Packs segment was a major growth contributor, registering a robust 28.3% QoQ increase in volumes.Content is external broker report sourced from online content aggregator through publicly available sources and is displayed below for general informational purposes only. Refer full disclaimer below.

Mold-Tek Packaging - Beat On All Fronts; Maintain BUY

<ul><li>Momentum in Pharma and F&amp;F Segment: The pharma division witnessed strong momentum in Q4, with sales nearly tripling to Rs 6.67 Cr compared to Q3, crossing the break-even threshold and beginning to contribute positively to profitability.</li><li>For FY26, the management is targeting revenue of Rs 30–35 Cr from the pharma segment, supported by planned capacity expansions and product diversification by Q1/Q2 FY26.</li><li>With enhanced IML printing capacities, the F&amp;F segment recorded robust sales growth of 25.5% in Q4.</li></ul>Content is external broker report sourced from online content aggregator through publicly available sources and is displayed below for general informational purposes only. Refer full disclaimer below.

Momentum in Pharma and F&amp;F Segment: The pharma division witnessed strong momentum in Q4, with sales nearly tripling to Rs 6.67 Cr compared to Q3, crossing the break-even threshold and beginning to contribute positively to profitability.For FY26, the management is targeting revenue of Rs 30–35 Cr from the pharma segment, supported by planned capacity expansions and product diversification by Q1/Q2 FY26.With enhanced IML printing capacities, the F&amp;F segment recorded robust sales growth of 25.5% in Q4.Content is external broker report sourced from online content aggregator through publicly available sources and is displayed below for general informational purposes only. Refer full disclaimer below.

Mold-Tek Packaging - Turn Around Ahead; Maintain BUY

<ul><li>Mold-Tek Packaging Ltd, established in 1985, pioneered the introduction of IML technology in India and has emerged as the country’s largest producer of plastic packaging pails.</li><li>The company has built a well-diversified business model, catering to varied markets and product segments to meet evolving customer requirements.</li><li>Its portfolio includes pharma packs, paints packs, lubricants packs, food and FMCG packs, all unified under a single platform. </li></ul>Content is external broker report sourced from online content aggregator through publicly available sources and is displayed below for general informational purposes only. Refer full disclaimer below.

Mold-Tek Packaging Ltd, established in 1985, pioneered the introduction of IML technology in India and has emerged as the country’s largest producer of plastic packaging pails.The company has built a well-diversified business model, catering to varied markets and product segments to meet evolving customer requirements.Its portfolio includes pharma packs, paints packs, lubricants packs, food and FMCG packs, all unified under a single platform. Content is external broker report sourced from online content aggregator through publicly available sources and is displayed below for general informational purposes only. Refer full disclaimer below.

Axis Punch - Mold-Tek Packaging Ltd: 17th April, 2025

<ul><li>We recently visited Mold-Tek Packaging’s plants (Unit 1 and Unit 10) in Hyderabad and interacted with the management.</li><li>Unit 1 is the company’s oldest facility, housing an in-house tool room and producing food and Q-pack products.</li><li>Unit 10 primarily focuses on pharma products alongside food packaging.</li></ul>Content is external broker report sourced from online content aggregator through publicly available sources and is displayed below for general informational purposes only. Refer full disclaimer below.

We recently visited Mold-Tek Packaging’s plants (Unit 1 and Unit 10) in Hyderabad and interacted with the management.Unit 1 is the company’s oldest facility, housing an in-house tool room and producing food and Q-pack products.Unit 10 primarily focuses on pharma products alongside food packaging.Content is external broker report sourced from online content aggregator through publicly available sources and is displayed below for general informational purposes only. Refer full disclaimer below.

Mold-Tek Packaging Ltd - Hyderabad Plant Visit & Management Meet Update

India

Mold-Tek Packaging Ltd. manufactures plastic packaging products.  The Company manufactures bottles for pharmaceuticals and cosmetics; child-resistant caps; flip-top tablet packs; blow-molded shampoo and medicine packs; and injection-molded pails for lubricants, chemicals, paint, ink, adhesives and bulk drugs.

Price Gauge
52-week Range	0.00 - 0.00
Market Cap (USDm)	0.00
P/E	0.00
Dividend (Yield)	0.00

Mold Tek Packaging (MTEP IN)

Mold-Tek Packaging - Performance In Line with Expectations; Maintain BUY

The pharma packaging segment continued to deliver robust growth, with revenue increasing 45% QoQ to Rs 10.8 Cr, albeit on a low base (Rs 7.4 Cr in...

Axis Direct

Mold-Tek Packaging - Beat On All Fronts; Maintain BUY

The company reported strong volume growth of 15% YoY and 16.9% QoQ, indicating sustained operational momentum across all major business verticals.

Axis Direct

Mold-Tek Packaging - Turn Around Ahead; Maintain BUY

The pharma division witnessed strong momentum in Q4, with sales nearly tripling to Rs 6.67 Cr compared to Q3 crossing the break-even threshold and...

Axis Direct

Axis Punch - Mold-Tek Packaging Ltd: 17th April, 2025

Mold-Tek Packaging Ltd, established in 1985, pioneered the introduction of IML technology in India and has emerged as the country’s largest...

Axis Direct

Mold-Tek Packaging Ltd - Hyderabad Plant Visit & Management Meet Update

Mold-Tek is the first company in India to introduce the “In-Mold Labeling (IML)” concept for decorating plastic containers with superior output.

Axis Direct

Price Gauge

52-week Range

Market Cap (USDm)

P/E

Dividend (Yield)